Radiation therapy, widely used in the treatment of a variety of malignancies in the pelvic area, is associated with inevitable damage to the surrounding healthy tissues. We have applied atomic force microscopy (AFM) to track the early damaging effects of ionizing radiation on the collagen structures in the experimental animals’ bladder and rectum. The first signs of the low-dose radiation (2 Gy) effect were detected by AFM as early as 1 week postirradiation. The observed changes were consistent with initial radiation destruction of the protein matrix. The alterations in the collagen fibers’ packing 1 month postirradiation were indicative of the onset of fibrotic processes. The destructive effect of higher radiation doses was probed 1 day posttreatment. The severity of the radiation damage was proportional to the dose, from relatively minor changes in the collagen packing at 8 Gy to the growing collagen matrix destruction at higher doses and complete three-dimensional collagen network restructuring towards fibrotic-type architecture at the dose of 22 Gy. The AFM study appeared superior to the optical microscopy-based studies in its sensitivity to early radiation damage of tissues, providing valuable additional information on the onset and development of the collagen matrix destruction and remodeling.

Radical radiotherapy to the bladder for muscle-invasive bladder cancer is a challenging treatment to plan and deliver because of organ mobility and its varying volume. The dynamic target volume can be tracked with imaging during the treatment course, enabling an adaptive response and adjustment of the patient’s individual treatment plan. This article summarises the difficulties encountered when treating the bladder, different approaches to patient imaging and adaptive radiotherapy techniques. Ultimately these technological advances support the delivery of a personalised treatment plan to ensure optimal dose delivery to the tumour and simultaneous sparing of adjacent normal tissue.

To evaluate the usefulness of the volumetric fluid balance for indicating and quantifying fluid absorption during transurethral resection of the prostate, 62 patients showing fluid absorption on ethanol monitoring (control method) were selected from a series of 410 operations. The volumetric fluid balance, which was measured as the difference between the input and output of irrigating fluid with and without a correction for the blood loss, proved to be an unreliable clinical tool for measuring the absorption. It indicated that fluid absorption occurred only in 40 or 18 of the 62 patients, depending on whether a correction for blood loss was made or not, the volume being only 59% and 71% (median), respectively, of that obtained by the control method. The absorption averaged 1 L in the patients in whom the volumetric measurements did not indicate absorption. The incidence of symptoms of the ‘transurethral resection syndrome’ increased with the absorbed fluid volume only when measured by the control method.